Trimetazidine combined with metoprolol improves therapeutic outcomes in patients with coronary heart disease complicated by heart failure. [PDF]
Liang X, Wang F, Bai Z.
europepmc +1 more source
Trimetazidine in the Treatment of Angina Pectoris
P, Brodbin, C A, O'Connor
openaire +2 more sources
An international, double-blind, randomized, placebo-controlled clinical trial of adjunctive trimetazidine to treat people with bipolar depression (the TIDE trial) protocol. [PDF]
Kim JH +27 more
europepmc +1 more source
[Trimetazidine-induced parkinsonism].
Eight patients, six women and two men, ages between 72 and 94 years (mean age 80), suffered from parkinsonism while taking trimetazidine, seven of them for a 6 to 12 months time period and the other for 9 years. The parkinsonism reverted after drug withdrawal. This is the first report of trimetazidine induced parkinsonism.
openaire +1 more source
Personalized management of angina and heart failure in clinical practice in the Middle East: a narrative review. [PDF]
Ali JA +4 more
europepmc +1 more source
A 46-Year-Old Man Presenting With Chest Pain Due to Apical Hypertrophic Cardiomyopathy (Yamaguchi Syndrome) Diagnosed by Multimodal Cardiac Imaging. [PDF]
Passos MD +5 more
europepmc +1 more source
Therapeutic targeting of mitochondrial dysfunction in heart failure: a systematic review & meta-analysis of clinical outcomes. [PDF]
Mohammed O +11 more
europepmc +1 more source
Effect of trimetazidine on early and delayed doxorubicin myocardial toxicity.
The influence of the administration of trimetazidine on the myocardial toxicity induced by doxorubicin was studied on an in vivo model in the rat. Trimetazidine was chosen due to its ability to act as a scavenger of oxygen-derived free radicals, which ...
Piccinini F. +3 more
core
Mitophagy as an active regulator of cardiac metabolic reprogramming. [PDF]
Gai L, Li Y, Yang C, Wang M.
europepmc +1 more source

